As of November 2024 Halozyme Therapeutics has a market cap of ₹501.87 Billion. This makes Halozyme Therapeutics the world's 2435th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 14th, 2024 the market cap of Halozyme Therapeutics was reported to be: